Immutep director reports shares and rights holdings
IMMUTEP Ltd director Elisabeth Amanda Boyce reports direct ownership of 423,288 Ordinary Shares and several performance rights over additional shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
IMMUTEP Ltd director Elisabeth Amanda Boyce reports direct ownership of 423,288 Ordinary Shares and several performance rights over additional shares. These performance rights have a $0.00 exercise price and, if vesting conditions are met, are scheduled to vest in tranches on December 1, 2026, December 1, 2027, and December 1, 2028, with expiration dates extending to November 23, 2028 and December 2, 2030.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Boyce Elisabeth Amanda
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Performance rights (right to receive) — 873,899 contracts (Direct);
Ordinary Shares — 423,288 shares (Direct)
Footnotes (4)
- F1. Granted on November 23, 2023. 166,667 performance rights will vest on December 1, 2026 dependent on Ms. Boyce meeting the vesting conditions.
- F2. Granted on December 2, 2025. 115,262 performance rights will vest on December 1, 2026 and the vesting of the remaining 591,970 performance rights is dependent on Ms. Boyce meeting the vesting conditions.
- F3. Granted on December 2, 2025. 295,985 performance rights will vest on December 1, 2027 and the vesting of the remaining 295,985 performance rights is dependent on Ms. Boyce meeting the vesting conditions.
- F4. Granted on December 2, 2025. 295,985 performance rights will vest on December 1, 2028 dependent on Ms. Boyce meeting the vesting conditions.
Key Figures
Direct Ordinary Shares: 423,288 shares
Performance rights grant 1: 166,667 rights
Performance rights grant 2 (2026 vesting): 115,262 rights
+5 more
8 metrics
Direct Ordinary Shares
423,288 shares
Directly held Ordinary Shares following reporting
Performance rights grant 1
166,667 rights
Granted November 23, 2023; vest on December 1, 2026 if conditions met
Performance rights grant 2 (2026 vesting)
115,262 rights
Granted December 2, 2025; vest on December 1, 2026 if conditions met
Performance rights grant 3 (2027 vesting)
295,985 rights
Granted December 2, 2025; vest on December 1, 2027 if conditions met
Performance rights grant 4 (2028 vesting)
295,985 rights
Granted December 2, 2025; vest on December 1, 2028 if conditions met
Exercise price of rights
$0.00 per share
Exercise price for all reported performance rights
Earliest rights expiration
November 23, 2028
Expiration date for first performance rights grant
Latest rights expiration
December 2, 2030
Expiration date for later performance rights grants
Key Terms
Performance rights (right to receive), vesting conditions, Ordinary Shares, beneficial ownership
4 terms
Performance rights (right to receive) financial
"Security title listed as "Performance rights (right to receive)" linked to Ordinary Shares."
vesting conditions financial
"Footnotes state that vesting is dependent on Ms. Boyce meeting the vesting conditions."
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
beneficial ownership financial
"Form 3 serves as an initial statement of beneficial ownership by the director."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does IMMUTEP (IMMP) director Elisabeth Boyce currently hold in company securities?
Elisabeth Amanda Boyce directly holds 423,288 Ordinary Shares of IMMUTEP Ltd. She also holds multiple tranches of performance rights, each linked to Ordinary Shares, which may vest in future years if specified vesting conditions are satisfied.
What are the performance rights reported by IMMUTEP (IMMP) director Elisabeth Boyce?
The performance rights are rights to receive Ordinary Shares at an exercise price of $0.00. They were granted in November 2023 and December 2025 and will convert into shares only if the stated vesting conditions are met.
When do Elisabeth Boyce’s IMMUTEP (IMMP) performance rights vest?
One grant of 166,667 performance rights is scheduled to vest on December 1, 2026, while additional grants, including tranches of 115,262 and 295,985 rights, are scheduled to vest on December 1, 2026, December 1, 2027, and December 1, 2028, subject to vesting conditions.
What are the expiration dates of IMMUTEP (IMMP) director Elisabeth Boyce’s performance rights?
The performance rights over IMMUTEP Ordinary Shares carry expiration dates of November 23, 2028 and December 2, 2030. If vesting conditions are not met or rights are not exercised by these dates, the corresponding rights would lapse according to the grant terms.
What is the exercise price of IMMUTEP (IMMP) performance rights held by Elisabeth Boyce?
Each reported performance right has an exercise price of $0.00 per Ordinary Share. This means that, if vesting conditions are fulfilled, the corresponding shares can be issued to Elisabeth Boyce without additional cash payment to acquire those specific shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates